Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
9,679 total articles
On March 20, Super Micro saw its stock fall sharply after U.S. prosecutors charged three people connected to the company with participating in an alleged plot to divert billions of dollars of U.S. AI technology to China. The company said it was not listed as a defendant, cooperated with investigators and has placed the employees on leave while seve…
UBS has retained an "Attractive" rating on global equities even as it flags heightened energy-related downside risks following disruptions to flows through the Strait of Hormuz. The bank expects de-escalation within weeks, projects 12% earnings growth for the MSCI AC World Index this year, and recommends diversified exposure to structural themes wh…
Prestige Consumer Healthcare will purchase the Breathe Right brand and related assets from Foundation Consumer Healthcare for $1.045 billion, a figure that falls to about $900 million after tax benefits. The acquisition, which is expected to close in the first half of 2027, brings a brand that generated roughly $200 million in revenue and $95 milli…
Oil prices remained high on Friday amid sustained fears that damage to energy infrastructure and attacks tied to the Iran conflict will restrict supplies for an extended period. Brent crude held near $108 a barrel after touching roughly $119 earlier in the week following strikes on Iranian and regional natural gas facilities. Damage to major produc…
Eris Lifesciences has released a generic version of semaglutide in India under the brand name Sundae, offering a 2 mg vial at 1,290 rupees per month (about $13.8). The company and its partner Natco Pharma are pricing the injectable well below established branded competitors, and Eris will introduce a pen device with multiple dosages in April.
Dell Technologies stock rose modestly while Super Micro Computer plunged after U.S. prosecutors charged a co-founder and two associates with diverting billions of dollars in Nvidia-powered servers to China in violation of export controls. The criminal indictment and ensuing market reaction raise reputational and control-related concerns for Super M…
UBS maintains an "Attractive" rating on U.S. equities, projecting the S&P 500 will climb to 7,300 by June and 7,700 by December 2026. The bank points to healthy corporate profit growth, anticipated Federal Reserve rate cuts, and value creation from AI adoption as key supports, while warning that prolonged disruptions to Persian Gulf energy flows co…
Rhythm Pharmaceuticals saw its stock rise after the FDA approved IMCIVREE (setmelanotide) to treat acquired hypothalamic obesity in patients aged 4 years and older, based on positive Phase 3 TRANSCEND trial results showing a statistically significant placebo-adjusted reduction in BMI. The drug will be available to U.S. patients immediately.
UBS Switzerland AG’s Chief Investment Office anticipates continued positive earnings growth for Swiss equities even as the US-Iran conflict and US trade policy create uncertainty for corporate planning. In a low-rate environment, the bank views the roughly 3% dividend yield on Swiss stocks as attractive and recommends concentrating on high-quality,…
UBS reaffirmed a constructive stance on emerging market equities, keeping its MSCI Emerging Markets target at 1,720 for December 2026. The bank upgraded South Korea to an "attractive" rating after a roughly 20% correction it attributes to technical selling rather than deteriorating fundamentals. UBS pointed to resilient earnings in memory and semic…
UBS has raised its Euro Stoxx 50 price objectives for 2026, citing an anticipated rebound in Eurozone corporate earnings after three years of flat performance. The bank projects mid-single-digit earnings growth in 2026 and stronger gains in 2027, driven by manufacturing momentum, contained inflation, clarified trade dynamics and supportive macro po…
Jefferies downgraded InPost S.A. to "hold" from "buy" and cut its price target to €15.60 after the company reported fourth-quarter adjusted EBITDA below consensus and outlined a capital-intensive expansion that will compress margins through 2026. The new target aligns with a recommended €15.60-per-share cash offer from a shareholder consortium led …
India's equity benchmarks finished higher on Friday, with the Nifty 50 up 0.49% and the BSE Sensex 30 up 0.44%. Technology, metals and power stocks were among the session's strongest performers, while several major financial names fell and hit 52-week lows. Market breadth was positive on both exchanges as volatility measures and key commodity and c…
Major U.S. airlines are projecting confidence about passenger demand and their ability to pass on rising jet fuel costs even as fuel prices have spiked and aviation across Europe and Asia contends with airspace disruptions. U.S. executives say fare increases and tight domestic capacity are helping offset higher fuel bills, while many overseas carri…
UBS Group's efforts to revive its U.S. wealth management arm are encountering headwinds after substantial asset outflows and the loss of close to 200 financial advisers. The firm recorded $14.1 billion of net new asset outflows in the Americas in the fourth quarter and a $6 billion net outflow for the year, while facing pressure from anticipated Sw…
Amazon is developing a new smartphone, internally called "Transformer," designed to strengthen ties between a personal mobile device and its Alexa voice assistant and Prime services. The project, led by a year-old ZeroOne group, seeks to embed artificial intelligence into a handset that could shift the role of app stores and serve as a daily condui…
U.S. equities have entered a period of heightened volatility, with the S&P 500 trading more than 5% below its January record high for the first time since November. The retreat has been driven in part by escalating tensions involving Iran and rising crude oil prices that have revived inflation worries. Historical patterns show many 5% pullbacks rec…
Infineon Technologies shares rose more than 3% after J.P. Morgan upgraded the company to overweight from neutral and lifted its price target to €48. The bank pointed to accelerating demand for AI power components, supply limitations driving pricing power, and signs that automotive market pressures could ease by the second half of 2026.
Novartis has struck an agreement to purchase SNV4818, an experimental breast cancer drug candidate from U.S. biotech Synnovation Therapeutics, for a total potential consideration of up to $3 billion. The transaction consists of a $2 billion upfront payment and as much as $1 billion tied to future development milestones. SNV4818 is a selective PI3Ka…
JPMorgan Chase will issue reports to junior investment bankers that juxtapose computer-generated estimates of their weekly work hours with the hours they record on time sheets. The estimates are produced from a digital footprint that includes video calls, desktop keystrokes and scheduled meetings. The initiative is being piloted and is expected to …
Indonesia's benchmark IDX Composite Index rose 1.20% at the close on Friday, propelled by strength in the Infrastructure, Financials and Agriculture sectors. A handful of individual stocks posted large percentage gains and losses, while oil, gold and currency pairs recorded modest moves in overseas trading.
Europe’s STOXX 600 recorded a modest intraday gain on Friday but was poised for a third straight weekly drop as a widening conflict in the Middle East and a recent spike in oil prices heightened inflation worries and raised the likelihood of further European Central Bank rate action. Financials led gains while energy lagged, and Unilever shares cli…
European stock indexes rose at the open on Friday, recovering from a sharp decline the prior session as investors weighed lower oil prices against an escalating Middle East conflict that has prompted attacks on gas infrastructure. Benchmarks including the Stoxx 600, Dax, CAC 40 and FTSE 100 posted gains by early morning trading, while concerns abou…
Barclays has begun covering CVS Group Plc at an "equal weight" rating with a 1,340 pence target, pointing to acquisitions in Australia that are forecast to produce returns below its cost of capital, competitive pressures in the UK market and limited short-term trading clarity. The bank flags cohort variability in acquisition returns, execution risk…
Japan's stock market closed lower on Friday, with the Nikkei 225 ending the session down 3.38% as declines in the Paper & Pulp, Transport and Communication sectors dragged the index down. Individual movers included notable gains for BayCurrent Consulting, Furukawa Electric and Inpex, while Sumitomo Metal Mining, Taiheiyo Cement and Tokyo Electric P…
